Blindness and symmetrical neurological deficit in a patient with colon cancer receiving adjuvant chemotherapy : is it always cancer?

Posterior reversible leukoencephalopathy syndrome [PRES] is characterized by a symmetrical brain edema. It is rarely caused by chemotheraphy. While steroids can lead to deterioration in the condition of a PRES patient, they are still the drug of choice for the more common condition of brain edema secondary to metastases. We describe the case of a colon cancer patient who underwent adjuvant treatment with capecitabine and oxaliplatin and was admitted to the hospital with seizures and brain edema. On admission, the condition was attributed to brain metastases and hence a high dose steroid treatment was initiated. Later on, as the patient became comatose, the CT was revised and PRES was suggested as an alternative diagnosis. After tapering the steroids the patient gradually recovered. This report emphasizes the need to be alert and not to confuse PRES with brain metastasis in cancer patients.

Medienart:

Artikel

Erscheinungsjahr:

2014

Erschienen:

2014

Enthalten in:

Zur Gesamtaufnahme - volume:153

Enthalten in:

Harefuah - 153(2014), 11 vom: 26. Nov., Seite 650-1, 687

Sprache:

Hebräisch

Beteiligte Personen:

Leshem, Yasmin [VerfasserIn]
Fennig, Shlomit [VerfasserIn]
Talianski, Elisa [VerfasserIn]
Greenberg, Gahl [VerfasserIn]
Wolf, Ido [VerfasserIn]

Themen:

04ZR38536J
0W860991D6
6804DJ8Z9U
Capecitabine
Case Reports
Deoxycytidine
Fluorouracil
Journal Article
Organoplatinum Compounds
Oxaliplatin
Steroids
U3P01618RT

Anmerkungen:

Date Completed 22.01.2015

Date Revised 02.12.2018

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM245098763